Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO

Insilico Medicine, a Hong Kong and New York-based company that uses AI for drug discovery, has filed for an initial public offering in the Asian financial hub that’s slowly recovering … Read More